Insulin-like Growth Factors II exon 9 and E-cadherin-Pml I but not Myeloperoxidase Promoter-463, Urokinase-ApaL I nor Xeroderma Pigmentosum Polymorphisms Are Associated with Higher Susceptibility to Leiomyoma
顯示簡易詮釋資料 統計資料| 欄位 | 內容 | 語言 |
|---|---|---|
dc.citation.epage |
2208 | en_US |
dc.citation.issue |
6 | en_US |
dc.citation.spage |
2203 | en_US |
dc.citation.volume |
30 | en_US |
dc.citation.woscount |
2 | |
dc.contributor.author |
Hsieh, Yao-Yuan | en_US |
dc.contributor.author |
Chang, Chi-Chen | en_US |
dc.contributor.author |
Wang, Yu-Kuo | en_US |
dc.contributor.author |
Hsu, Kung-Hao | en_US |
dc.contributor.author |
Chen, Chih-Ping | en_US |
dc.contributor.author |
Hsu, Chin-Mu | en_US |
dc.contributor.author |
Tsai, Fuu-Jen | en_US |
dc.contributor.department |
生物科技學系 | zh_TW |
dc.contributor.department |
Department of Biological Science and Technology | en_US |
dc.date.accessioned |
2014-12-08T15:06:48Z | |
dc.date.available |
2014-12-08T15:06:48Z | |
dc.date.issued |
2010-06-01 | en_US |
dc.description.abstract |
Objectives: To investigate the roles of insulin-like growth factor II (IGF2), myeloperoxidase (MPO), E-cadherin (CDH1), urokinase and xeroderma pigmentosum group A and D (XPA, XPD) polymorphisms upon leiomyoma susceptibility. Study Design: Women were divided into: group I, leiomyoma (n=158); group 2, non-leiomyoma (n=156). Polymorphisms (IGF2 exon 9*A/G, MPO-463*A/G, CDH1-Pml I, urokinase-ApaL, XPA*A-23G, XPD*Lys751Gln) were amplified by polymerase chain reaction and detected by electrophoresis after restriction enzyme digestion. Genotype and allelic frequencies were compared between both groups. Results: Associations between leiomyoma with IGF2 and CDH1 polymorphism exist. Proportions of IGF2 exon 9*AA/AG/GG in and CDH1* CC/CT/TT in the groups were: group I, 38/39.2/22.8% and 27.8/66.5/5.7%; group 2, 22.4/53.9/23.7% and 21.2/64.1/14.7. MPO, urokinase, XPA and XPD in both groups were non-significantly different. Proportions of MPO*AA/AG/GG, urokinase*CC/CT/TT, XPA*AA/AG/GG and XPD*AA/AC/CC were: group 1: 1.9/23.4/74.7%, 0.6/7/92.4%, 20.9/55.1/24%, 85.4/14.6/0%; group 2: 3.8/24.4/71.8%, 1.3/4.5/94.2%, 22.4/53.9/23.7%, 84.6/15.4/0%. Conclusion: IGF2*A allele and CDH1*C allele were correlated with leiomyoma susceptibility, which may be associated with leiomyoma development. MPO, urokinase, XPA and XPD polymorphisms are not related to leiomyoma susceptibilities. | en_US |
dc.identifier.issn |
0250-7005 | en_US |
dc.identifier.journal |
ANTICANCER RESEARCH | en_US |
dc.identifier.uri |
https://ir.lib.nycu.edu.tw/handle/11536/5337 | |
dc.identifier.wosnumber |
WOS:000280230300042 | |
dc.language.iso |
en_US | en_US |
dc.subject |
Cadherin | en_US |
dc.subject |
insulin-like growth factor | en_US |
dc.subject |
leiomyoma | en_US |
dc.subject |
myeloperoxidase | en_US |
dc.subject |
polymorphism | en_US |
dc.subject |
urokinase | en_US |
dc.subject |
xeroderma pigmentosum | en_US |
dc.title |
Insulin-like Growth Factors II exon 9 and E-cadherin-Pml I but not Myeloperoxidase Promoter-463, Urokinase-ApaL I nor Xeroderma Pigmentosum Polymorphisms Are Associated with Higher Susceptibility to Leiomyoma | en_US |
dc.type |
Article | en_US |
檔案
- 000280230300042.pdf (65.2 KB, Adobe PDF)
所屬典藏: 期刊論文
引用此條目
Hsieh, Y.-Y., Chang, C.-C., Wang, Y.-K., Hsu, K.-H., Chen, C.-P., Hsu, C.-M., & Tsai, F.-J. (2010). Insulin-like Growth Factors II exon 9 and E-cadherin-Pml I but not Myeloperoxidase Promoter-463, Urokinase-ApaL I nor Xeroderma Pigmentosum Polymorphisms Are Associated with Higher Susceptibility to Leiomyoma. ANTICANCER RESEARCH, 30(6), 2203–2208. https://ir.lib.nycu.edu.tw/handle/11536/5337
引用文字依 APA 第 7 版格式自動產生,使用前請再核對。
分享
永久網址:https://ir.lib.nycu.edu.tw/handle/11536/5337